Medicine and Dentistry
Association
100%
Diabetes
100%
Retrospective Cohort Study
100%
Glycon
100%
Medication
100%
Adult
57%
COVID-19
57%
Mortality
42%
Dipeptidyl Peptidase-4 Inhibitor
42%
Severe Acute Respiratory Syndrome Coronavirus 2
42%
Sulfonylurea
42%
Therapeutic Procedure
28%
Outpatient
28%
Type 2 Diabetes
28%
Tissues
14%
Vaccine
14%
Child
14%
Combination Therapy
14%
Infection
14%
In Vitro
14%
Pregnancy
14%
Maturity Onset Diabetes of the Young
14%
Cohort Analysis
14%
Age
14%
Monotherapy
14%
Male
14%
In Silico
14%
Artificial Respiration
14%
Backache
14%
Post-Exposure Prophylaxis
14%
Viral Life Cycle
14%
Severe Acute Respiratory Syndrome
14%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
100%
Diabetes Mellitus
100%
Metformin
100%
Mortality
42%
SARS Coronavirus
42%
Sulfonylurea
42%
Dipeptidyl Peptidase IV Inhibitor
42%
Vaccine
14%
Infection
14%
Monotherapy
14%
Non Insulin Dependent Diabetes Mellitus
14%
Severe Acute Respiratory Syndrome
14%
Backache
14%